Old Articles: <Older 611-620 Newer> |
|
BusinessWeek January 6, 2011 C. Benson et al. |
Nasdaq's Secret Agent Derivatives Campaign The exchange wants to limit banks' ownership of clearinghouses |
BusinessWeek January 6, 2011 |
How the Nasdaq Lobbying Worked Stealth lobbying lead to a Justice Dept. investigation. In 2008, Nasdaq began clearing over-the-counter swaps of interest rates, commonly used to hedge against higher borrowing costs or to speculate on interest-rate moves. |
Chemistry World January 4, 2011 Andrew Turley |
Funding pharma whistleblowers Hedge fund managers say that US whistleblower lawsuits filed against drug companies could provide attractive investment opportunities. |
The Motley Fool December 30, 2010 Roger Friedman |
3 Volatile Stocks Worth Watching Advisor Jeff Fischer weighs in with stock and options ideas. |
On Wall Street January 1, 2011 Nick Barisheff |
The New Gold Rush A look at four of gold's most important rules; the irreversible trends affecting the gold price; and how the consequences of these trends will push gold higher in 2011 and beyond. |
The Motley Fool December 22, 2010 Sean Sun |
How We're Shorting Lender Processing Services The devil's in the details. |
The Motley Fool December 22, 2010 Sean Sun |
How We're Shorting Bank of America We think Bank of America and Lender Processing Services are going down. |
The Motley Fool December 15, 2010 Alex Dumortier |
5 Cheap Stocks, 1 Rich Trade Right now, two factors are combining to produce opportunities for enormous gains on specific stock option trades. |
The Motley Fool December 14, 2010 Brian Orelli |
3 Ways to Play Biotech With Options Are you looking for a way for options to help you decrease the risk of investing in biotechnology? Then read on. |
The Motley Fool December 13, 2010 Bryan Hinmon |
A Better Way to Play a "Once in a Lifetime Opportunity" A primer on diagonal calls. |
<Older 611-620 Newer> Return to current articles. |